Calgary, Alberta, Canada – October 29, 2025 – TheNewswire - Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (OTC Pink:VYYRF) (“Voyageur” or the “Company”), a Canadian public company developing cost-effective imaging contrast media products, is pleased to announce the signing of a Non Exclusive Distribution Agreement with PHALANX, Comercializadora e Importadora de Componentes SA DE CV ("Phalanx"),  a company based in Mexico. This agreement was established after the signing of a non-binding Letter of Intent ("LOI") ...